During the past decade, Osaka Medical College Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka Medical College Hospital" #1 sponsor was "BeiGene" with 1 trials, followed by "CG Oncology, Inc." with 1 trials sponsored, "Chugai Pharmaceutical" with 1 trials sponsored, "Five Prime Therapeutics, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka Medical College Hospital" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Osaka Medical College Hospital" are "Hypercholesterolemia" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atherosclerosis" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Osaka Medical College Hospital" in a lesser frequency.

Most popular intervention types in "Osaka Medical College Hospital" are "Drug" (4 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Atezolizumab" (1 trials), "Bemarituzumab" (1 trials), "CG0070" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osaka Medical College Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Osaka Medical College Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Osaka Medical College Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osaka Medical College Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".